Quality risk management is a core requirement of the Annex 1 revision, with regulators nudging the industry towards adopting a proactive approach to risk assessment.
This webinar considers the appropriate areas to assess, including contamination control and sterility assurance.
Dr. Tim Sandle has over twenty-five years’ experience of microbiological research and biopharmaceutical processing. He is a member of several editorial boards and he has written over six hundred book chapters, peer reviewed papers and technical articles relating to microbiology. Dr. Sandle works for a pharmaceutical manufacturer in the UK, and is a visiting tutor at both the University of Manchester and UCL.